Dr. Kerlin is the Director of the Hemophilia and Bleeding Disorder Program for Nationwide Children's Hospital Hemostasis and Thrombosis Center and a member of the Division of Hematology/Oncology/BMT.
The Hemostasis and Thrombosis Center at Nationwide Children's is the largest and only federally recognized pediatric Hemophillia Treatment Center’s in Central Ohio. Considered an area of medicine that requires specific expertise, Children’s specializes in care of children and adolescents with Hemophillia and other bleeding disorders, thrombosis and stroke and ITP. As one of 130 centers in the national network of centers, Children’s provides services to children with bleeding disorders and thrombosis diseases according to guidelines that are developed and established by the National Hemophilia Foundation (NHF), Maternal and Child health Bureau (MCBH), and the Centers for Disease Control and Prevention (CSC).
What does having access to this type of program mean to our patients?
National studies have found that patients who receive treatment from an official HTC normally see lower mortality rates, fewer hospitalizations, less time lost from school or work and lower overall health care costs.